Faricimab Shows Promising Results in nAMD and PCV Trials
Results from the AVONELLE-X and SALWEEN trials have demonstrated the safety and effectiveness of faricimab (marketed as Vabysmo) in treating neovascular age-related macular degeneration (nAMD) and polypoidal choroidal vasculopathy (PCV).…